Verve Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Great. Okay. So I'm Eric Joseph, Senior Biotech Analyst with JPMorgan. Our next presenting company is Verve Therapeutics, and it's my pleasure to welcome Sekar Kathiresan, CEO, to take us through the story. There is a Q&A session after the presentation. There will be mics circulated around the room. And for those tuning in online, feel free to submit a question via the portal and I'll work those in where appropriate. So with that, Sekar, thanks for your time.
Okay. Good afternoon. Thank you to the JPM team and Eric for the opportunity to present our story today. My name is Sekar Kathiresan. Prior to founding and leading Verve, I spent 20 years as a cardiologist at Mass General Hospital practicing preventive cardiology and a professor at Harvard Medical School, researching the genetic basis of cardiovascular disease.
At Verve, we are looking to transform the care of cardiovascular
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
